Mark H. Dornan

We don’t have enough information about this author to calculate their statistics. If you think this is an error let us know.
Learn More
The use of engineered viral strains such as gene therapy vectors and oncolytic viruses (OV) to selectively destroy cancer cells is poised to make a major impact in the clinic and revolutionize cancer therapy. In particular, several studies have shown that OV therapy is safe and well tolerated in humans and can infect a broad range of cancers. Yet in(More)
  • 1